{rfName}
Pr

Indexed in

License and use

Icono OpenAccess

Citations

Altmetrics

Analysis of institutional authors

Notario, LAuthorPiulats, J MAuthorSala, NAuthorGonzalez, AAuthorEtxaniz, OAuthorVilla, SAuthorBoladeras, AAuthorDel Carpio, LAuthorRosello, AAuthorGarcia Del Muro, XAuthorEsteve, AAuthorFont, AAuthor

Share

Publications
>
Meeting Abstract

Prognostic significance of docetaxel (D) plus androgen-deprivation therapy (ADT) in patients (p) with metastatic castration-sensitive prostate cancer (mCSPC) according to extent of disease: A study of real-world data

Publicated to:Annals Of Oncology. 31 S532-S532 - 2020-09-01 31(), DOI: 10.1016/j.annonc.2020.08.914

Authors: Notario, L; Piulats, JM; Sala, N; Ferrándiz, U; González, A; Etxániz, O; Villà, S; Buisan, O; Boladeras, A; Heras, L; Del Carpio, L; Roselló, A; Barretina, P; Fina, C; Pardo, JC; Suárez, JM; Comet, J; del Muro, XG; Esteve, A; Font, A

Affiliations

Hosp Badalona Germans Trias & Pujol, Urol Dept, Barcelona, Spain - Author
Hosp Bellvitge Princeps Espanya, Urol Dept, Barcelona, Spain - Author
Hosp Josep Trueta, Urol Dept, Girona, Spain - Author
Inst Catala Oncol Badalona, Med Oncol Dept, Barcelona, Spain - Author
Inst Catala Oncol Girona, Radiat Oncol Dept, Girona, Spain - Author
Inst Catala Oncol Hosp, Med Oncol Dept, Barcelona, Spain - Author
Inst Catala Oncol Hosp, Med Oncol Dept, Girona, Spain - Author
Inst Catala Oncol Hosp, Radiat Oncol Dept, Barcelona, Spain - Author
See more

Abstract

Keywords

Ciências biológicas iCiências biológicas iiiFarmaciaGeneral medicineHematologyMedicina iMedicina iiMedicina iiiMedicine (miscellaneous)NutriçãoOncologySaúde coletiva

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Annals Of Oncology due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2020, it was in position 7/242, thus managing to position itself as a Q1 (Primer Cuartil), in the category Oncology. Notably, the journal is positioned above the 90th percentile.

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-06-20:

  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 1 (PlumX).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (NOTARIO RINCON, LUCÍA) and Last Author (Font Pous, Albert).